Balanced news tone
News Sentiment
3401 sentiment intelligence
Teijin Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
89/100 classification confidence.
directly relevant articles
high-authority source matches
-3.3% over one week, +1.5% over four weeks, trend active, and materially above fair value.
Teijin (TSE:3401) Pushes Higher This Year, Is The Upside Already Priced In?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Teijin (TSE:3401) Pushes Higher This Year, Is The Upside Already Priced In?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 12 Jul 2026 06:11
- Source
- Market source
Teijin (TSE:3401) Stock Could Be 8.3% Below Fair Value Despite Recovery Debate
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Market source
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 19 Jun 2026 07:00
- Source
- Market source
Assessing Teijin (TSE:3401) Valuation After Recent Share Price Momentum
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Market source
Teijin's Stock Rises Despite Forecasting ¥85 Billion Operating Loss for FY March 2026; Buyback on "Bad News Exhaustion" Sentiment
- Tone
- Negative 34/100
- Event
- Capital return
- Published
- 31 Mar 2026 07:00
- Source
- finance.biggo.com
Teijin Limited divests its automotive business in the US - JEC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Apr 2025 07:00
- Source
- Connecting the World with Composites
Aurelius Private Equity to acquire Teijin Automotive Technologies North America
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2025 07:00
- Source
- CompositesWorld
Teijin agrees to sell composites business subsidiary in Japan - JEC
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Aug 2024 07:51
- Source
- Connecting the World with Composites
Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Mar 2021 08:00
- Source
- Fierce Pharma
Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Feb 2021 08:00
- Source
- Business Wire
Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Feb 2021 08:00
- Source
- Reuters